Pulse Biosciences Inc. (PLSE)
NASDAQ: PLSE
· Real-Time Price · USD
17.25
0.23 (1.35%)
At close: May 01, 2025, 3:59 PM
17.20
-0.29%
After-hours: May 01, 2025, 06:08 PM EDT
1.35% (1D)
| Bid | 14 |
| Market Cap | 1.16B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -53.59M |
| EPS (ttm) | -0.92 |
| PE Ratio (ttm) | -18.75 |
| Forward PE | -36.4 |
| Analyst | n/a |
| Ask | 19.5 |
| Volume | 181,405 |
| Avg. Volume (20D) | 189,209 |
| Open | 17.18 |
| Previous Close | 17.02 |
| Day's Range | 17.02 - 17.54 |
| 52-Week Range | 6.66 - 25.00 |
| Beta | 1.88 |
About PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed i...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date May 18, 2016
Employees 75
Stock Exchange NASDAQ
Ticker Symbol PLSE
Website https://www.pulsebiosciences.com
1 month ago
+6%
Pulse Biosciences shares are trading higher. The c...
Unlock content with
Pro Subscription
2 months ago
+14.86%
Pulse Biosciences shares are trading higher after the company announced it appointed a new CFO.
2 months ago · businesswire.com
Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care ConferenceMIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced plans...